Company intelligence / Profile preview

SuperBetter

Ownership: Private
Development stage: Commercial

Overview

SuperBetter is validated in randomized controlled trials for improving mood, perceived social support, resilience, optimism, reducing symptoms of depression/anxiety/concussion among youth. It has been recognized as one of the most effective smartphone apps for these outcomes in meta-analysis studies.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapyDigital therapeuticGame-based interventionMobile app-based therapy
Industry: Digital Health Medical Devices

Partnerships

Collaborates with universities such as University of Pennsylvania and The Ohio State University Wexner Medical Center for research studies. Also partners with schools/universities/youth programs for implementation but no major pharma/biotech partnerships

Beyond the preview

Go deeper on SuperBetter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SuperBetter.

Explore the full profile